Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation
2004
Abstract
Refractory anemia; Refractory cytopenia with multilineage dysplasia; Prognosis; Karyotype; WHO classification; FAB classification; Myelodysplastic syndrome; Transplantation